Christoph Lengauer

Christoph Lengauer

Direktor/Vorstandsmitglied bei
Presage Biosciences, Inc.
61 Jahre
Health Technology
Consumer Services
Commercial Services

Profil

Christoph S.
Lengauer
was the founder of Celsius Therapeutics, Inc., founded in 2018, where the title held was President & Chief Technology Officer from 2018 to 2019.
Dr. Lengauer was the founder of Thrive Earlier Detection Corp., founded in 2019, holding the title Chief Innovation Officer & Director.
Current jobs include Director at Presage Biosciences, Inc. since 2015, Director at MOMA Therapeutics, Inc., and Director at IDRx, Inc. Former jobs include Executive Director & Senior Unit Head-Oncology at Novartis Institutes for Biomedical Research, Inc. from 2005 to 2008; Independent Director at Relay Therapeutics, Inc.; Independent Non-Executive Director at HOOKIPA Pharma, Inc. from 2018 to 2022; Coaching Director at Baltimore Bays Soccer Club; Associate Professor-Oncology at The Sidney Kimmel Comprehensive Cancer Center from 1997 to 2005; Venture Partner at Third Rock Ventures LLC from 2016 to 2018; Chief Scientific Officer & Chief Drug Hunter at Blueprint Medicines Corp.
from 2012 to 2016; and Vice President at Sanofi from 2008 to 2012.
Education includes an MBA from The Johns Hopkins University, graduate studies at Universität Salzburg, and a doctorate from Ruprecht-Karls-Universität Heidelberg.

Aktive Positionen von Christoph Lengauer

UnternehmenPositionBeginn
Direktor/Vorstandsmitglied 24.11.2015
Direktor/Vorstandsmitglied -
Direktor/Vorstandsmitglied -

Ehemalige bekannte Positionen von Christoph Lengauer

UnternehmenPositionEnde
HOOA PHARPAR Direktor/Vorstandsmitglied 30.06.2022
BLUEPRINT MEDICINES CORPORATION Technik-/Wissenschafts-/F&E-Leiter 21.11.2016
SANOFI Corporate Officer/Principal 01.01.2012
Direktor/Vorstandsmitglied 01.05.2008
Corporate Officer/Principal 01.01.2005
Sehen Sie sich die Erfahrung von Christoph Lengauer im Detail an

Ausbildung von Christoph Lengauer

Erfahrungen
Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Beziehungen

63

Beziehungen ersten Grades

16

Unternehmen ersten Grades

Herr

Frau

Aufsichtsräte

Führungskräfte

Unternehmensverbindungen

Private Unternehmen16

Health Technology

Health Technology

Consumer Services

Consumer Services

Consumer Services

Commercial Services

Health Services

Finance

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

  1. Börse
  2. Insiders
  3. Christoph Lengauer